CHEMED CORP (CHE) Fundamental Analysis & Valuation

NYSE:CHE • US16359R1032

399.55 USD
-3.17 (-0.79%)
At close: Mar 12, 2026
399.55 USD
0 (0%)
After Hours: 3/12/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, CHE scores 7 out of 10 in our fundamental rating. CHE was compared to 101 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CHE a very profitable company, without any liquidiy or solvency issues. CHE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. CHE Profitability Analysis

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • In the past 5 years CHE has always been profitable.
  • In the past 5 years CHE always reported a positive cash flow from operatings.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • CHE has a better Return On Assets (17.24%) than 100.00% of its industry peers.
  • CHE has a Return On Equity of 27.08%. This is amongst the best in the industry. CHE outperforms 92.08% of its industry peers.
  • With an excellent Return On Invested Capital value of 21.08%, CHE belongs to the best of the industry, outperforming 95.05% of the companies in the same industry.
  • CHE had an Average Return On Invested Capital over the past 3 years of 21.04%. This is significantly above the industry average of 8.98%.
  • The 3 year average ROIC (21.04%) for CHE is below the current ROIC(21.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROIC 21.08%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • CHE has a Profit Margin of 10.48%. This is amongst the best in the industry. CHE outperforms 96.04% of its industry peers.
  • In the last couple of years the Profit Margin of CHE has declined.
  • CHE has a Operating Margin of 14.01%. This is amongst the best in the industry. CHE outperforms 86.14% of its industry peers.
  • CHE's Operating Margin has declined in the last couple of years.
  • CHE has a better Gross Margin (32.54%) than 63.37% of its industry peers.
  • In the last couple of years the Gross Margin of CHE has remained more or less at the same level.
Industry RankSector Rank
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CHE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
  • The number of shares outstanding for CHE has been reduced compared to 1 year ago.
  • The number of shares outstanding for CHE has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CHE has a worse debt to assets ratio.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CHE has an Altman-Z score of 11.01. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CHE (11.01) is better than 97.03% of its industry peers.
  • CHE has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
  • CHE's Debt to FCF ratio of 0.03 is amongst the best of the industry. CHE outperforms 93.07% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that CHE is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.01, CHE belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Altman-Z 11.01
ROIC/WACC2.38
WACC8.86%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • CHE has a Current Ratio of 1.05. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CHE (1.05) is worse than 63.37% of its industry peers.
  • CHE has a Quick Ratio of 1.03. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • CHE has a worse Quick ratio (1.03) than 60.40% of its industry peers.
  • The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.03
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CHE Growth Analysis

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.70%.
  • CHE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.61% yearly.
  • Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 4.06% in the last year.
  • Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.00% on average per year.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%

3.2 Future

  • CHE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.57% yearly.
  • CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.60% yearly.
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

5

4. CHE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.51 indicates a rather expensive valuation of CHE.
  • Compared to the rest of the industry, the Price/Earnings ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 70.30% of the companies listed in the same industry.
  • CHE is valuated rather cheaply when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 16.48 indicates a correct valuation of CHE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 71.29% of the companies listed in the same industry.
  • CHE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 18.51
Fwd PE 16.48
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHE is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 68.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.9
EV/EBITDA 12.94
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.5
PEG (5Y)5.12
EPS Next 2Y12.04%
EPS Next 3Y10.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CHE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.58%, CHE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.49, CHE pays a better dividend. On top of this CHE pays more dividend than 81.19% of the companies listed in the same industry.
  • With a Dividend Yield of 0.58, CHE pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.58%

5.2 History

  • On average, the dividend of CHE grows each year by 11.06%, which is quite nice.
  • CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.06%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CHE pays out 11.95% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CHE Fundamentals: All Metrics, Ratios and Statistics

CHEMED CORP

NYSE:CHE (3/12/2026, 8:04:00 PM)

After market: 399.55 0 (0%)

399.55

-3.17 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners101.6%
Inst Owner Change42.44%
Ins Owners1.54%
Ins Owner Change-1.18%
Market Cap5.50B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target566.61 (41.81%)
Short Float %4.29%
Short Ratio3.2
Dividend
Industry RankSector Rank
Dividend Yield 0.58%
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)0%
PT rev (3m)-3.27%
EPS NQ rev (1m)-7.94%
EPS NQ rev (3m)-7.94%
EPS NY rev (1m)-5.51%
EPS NY rev (3m)-5.76%
Revenue NQ rev (1m)-2.14%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-1.39%
Valuation
Industry RankSector Rank
PE 18.51
Fwd PE 16.48
P/S 2.17
P/FCF 16.9
P/OCF 14.17
P/B 5.62
P/tB 23.96
EV/EBITDA 12.94
EPS(TTM)21.59
EY5.4%
EPS(NY)24.25
Fwd EY6.07%
FCF(TTM)23.64
FCFY5.92%
OCF(TTM)28.2
OCFY7.06%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.5
PEG (5Y)5.12
Graham Number185.88
Profitability
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROCE 28.33%
ROIC 21.08%
ROICexc 22.41%
ROICexgc 60.78%
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
FCFM 12.86%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Debt/EBITDA 0.03
Cap/Depr 96.84%
Cap/Sales 2.48%
Interest Coverage 263.51
Cash Conversion 92.61%
Profit Quality 122.71%
Current Ratio 1.05
Quick Ratio 1.03
Altman-Z 11.01
F-Score6
WACC8.86%
ROIC/WACC2.38
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.84%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%

CHEMED CORP / CHE FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 8 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 8 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to grow by 12.32% in the next year.